Have a feature idea you'd love to see implemented?
Let us know!
OPTN OptiNose Inc
Price (delayed)
$0.395
Market cap
$59.58M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.26
Enterprise value
$103.07M
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S.
Highlights
The equity has grown by 47% year-on-year and by 4.1% since the previous quarter
OPTN's EPS is up by 32% YoY and by 24% from the previous quarter
The quick ratio has dropped by 80% since the previous quarter but it is up by 28% year-on-year
Key stats
What are the main financial stats of OPTN
Market
Valuations
Earnings
Shares outstanding
150.83M
Market cap
$59.58M
Enterprise value
$103.07M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.36
Revenue
$75.67M
EBIT
-$10.85M
EBITDA
-$10.51M
Free cash flow
-$39.79M
Per share
Balance sheet
Liquidity
EPS
-$0.26
Free cash flow per share
-$0.23
Book value per share
-$0.27
Revenue per share
$0.43
TBVPS
$0.75
Total assets
$131.02M
Total liabilities
$172.12M
Debt
$125.99M
Equity
-$41.1M
Working capital
-$34.22M
Debt to equity
-3.07
Current ratio
0.79
Quick ratio
0.69
Net debt/EBITDA
-4.14
Margins
Efficiency
Dividend
EBITDA margin
-13.9%
Gross margin
90.2%
Net margin
-41.2%
Operating margin
-25.4%
Return on assets
-27.4%
Return on equity
N/A
Return on invested capital
-16.5%
Return on capital employed
N/A
Return on sales
-14.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OPTN stock price
How has the OptiNose stock price performed over time
Intraday
7.63%
1 week
-13.19%
1 month
-49.36%
1 year
-67.62%
YTD
-69.38%
QTD
-41.04%
Financial performance
How have OptiNose's revenue and profit performed over time
Revenue
$75.67M
Gross profit
$68.26M
Operating income
-$19.19M
Net income
-$31.15M
Gross margin
90.2%
Net margin
-41.2%
The operating margin has grown by 36% year-on-year
The operating income has increased by 33% year-on-year
OPTN's net margin is up by 27% YoY and by 24% QoQ
OptiNose's net income has increased by 24% from the previous quarter and by 24% YoY
Growth
What is OptiNose's growth rate over time
Valuation
What is OptiNose stock price valuation
P/E
N/A
P/B
N/A
P/S
0.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.36
OPTN's EPS is up by 32% YoY and by 24% from the previous quarter
The equity has grown by 47% year-on-year and by 4.1% since the previous quarter
OPTN's price to sales (P/S) is 76% less than its 5-year quarterly average of 3.5 and 58% less than its last 4 quarters average of 2.0
OptiNose's revenue has increased by 5% YoY
Efficiency
How efficient is OptiNose business performance
OPTN's ROS has soared by 53% YoY and by 49% from the previous quarter
The company's return on invested capital has surged by 51% QoQ
The ROA has grown by 29% from the previous quarter and by 21% YoY
Dividends
What is OPTN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OPTN.
Financial health
How did OptiNose financials performed over time
OptiNose's total assets is 24% less than its total liabilities
The quick ratio has dropped by 80% since the previous quarter but it is up by 28% year-on-year
OPTN's current ratio has dropped by 80% since the previous quarter but it is up by 32% year-on-year
OptiNose's debt to equity has shrunk by 84% YoY and by 5% QoQ
The equity has grown by 47% year-on-year and by 4.1% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.